Recombinant Proteins Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Product (Hormones, Cytokines, Plasma Protein Factor, Growth Factors, Recombinant Metabolic Enzymes and Others); Application (Drug Discovery & Development, Biopharmaceutical Production, Basic Research and Others); End User (Biopharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations and Others) and Geography
Report Code: TIPRE00003725 No. of Pages: 150 Category: Biotechnology Status: Upcoming
MARKET INTRODUCTION
Recombinant proteins are used for the development of novel therapies for the treatment of severe chronic diseases such as cancer and other rare diseases. Recombinant protein production requires a special technique called as recombinant DNA (rDNA) technology. The numerous advancement in pharmacological understanding and pharmaceutical production have allowed constant development of proteins as a vital therapeutic option in variety of human diseases. The recombinant proteins are used in various areas such as multiple sclerosis, dwarfism, anemia, diabetes, rheumatoid arthritis, Crohn's disease and others.
MARKET DYNAMICS
The recombinant proteins market is anticipated to grow in the forecast period owing to driving factors such as growing research & development expenditure on biologic drugs, technological advancement in production of recombinant protein and demand of recombinant therapeutic proteins. However, complex manufacturing process, higher costs and requirement of high quality of these products eventually hinders the market growth.
MARKET SCOPE
The "Global Recombinant Proteins Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of recombinant proteins market with detailed market segmentation by product, application, end user and geography. The global recombinant proteins market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading recombinant proteins market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global recombinant proteins market is segmented on the basis of product, application and end user. Based on product, the market is segmented as hormones, cytokines, plasma protein factor, growth factors, recombinant metabolic enzymes and others. The recombinant proteins market, based on application is segmented into drug discovery & development, biopharmaceutical production, basic research and others. The recombinant proteins market, based on end user is segmented into biopharmaceutical companies, academic & research institutes, contract research organizations and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global recombinant proteins market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The recombinant proteins market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting recombinant proteins market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the recombinant proteins market in these regions.
MARKET PLAYERS
The reports cover key developments in the recombinant proteins market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from recombinant proteins Market are anticipated to lucrative growth opportunities in the future with the rising demand for recombinant proteins in the global market. Below mentioned is the list of few companies engaged in the recombinant proteins market.
The report also includes the profiles of key recombinant proteins market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Recombinant proteins are used for the development of novel therapies for the treatment of severe chronic diseases such as cancer and other rare diseases. Recombinant protein production requires a special technique called as recombinant DNA (rDNA) technology. The numerous advancement in pharmacological understanding and pharmaceutical production have allowed constant development of proteins as a vital therapeutic option in variety of human diseases. The recombinant proteins are used in various areas such as multiple sclerosis, dwarfism, anemia, diabetes, rheumatoid arthritis, Crohn's disease and others.
MARKET DYNAMICS
The recombinant proteins market is anticipated to grow in the forecast period owing to driving factors such as growing research & development expenditure on biologic drugs, technological advancement in production of recombinant protein and demand of recombinant therapeutic proteins. However, complex manufacturing process, higher costs and requirement of high quality of these products eventually hinders the market growth.
MARKET SCOPE
The "Global Recombinant Proteins Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of recombinant proteins market with detailed market segmentation by product, application, end user and geography. The global recombinant proteins market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading recombinant proteins market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global recombinant proteins market is segmented on the basis of product, application and end user. Based on product, the market is segmented as hormones, cytokines, plasma protein factor, growth factors, recombinant metabolic enzymes and others. The recombinant proteins market, based on application is segmented into drug discovery & development, biopharmaceutical production, basic research and others. The recombinant proteins market, based on end user is segmented into biopharmaceutical companies, academic & research institutes, contract research organizations and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global recombinant proteins market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The recombinant proteins market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting recombinant proteins market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the recombinant proteins market in these regions.
MARKET PLAYERS
The reports cover key developments in the recombinant proteins market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from recombinant proteins Market are anticipated to lucrative growth opportunities in the future with the rising demand for recombinant proteins in the global market. Below mentioned is the list of few companies engaged in the recombinant proteins market.
The report also includes the profiles of key recombinant proteins market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Crown Bioscience Inc.
- Prospec-Tany Technogene Ltd.
- BPS Bioscience, Inc.
- Novoprotein
- PeproTech, Inc.
- Eli Lilly and Company
- Merck & Co., Inc.
- Proteintech Group
- GenScript
- GlaxoSmithKline plc
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Recombinant Proteins Market - By Product
1.3.2 Recombinant Proteins Market - By Application
1.3.3 Recombinant Proteins Market - By End User
1.3.4 Recombinant Proteins Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. RECOMBINANT PROTEINS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RECOMBINANT PROTEINS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. RECOMBINANT PROTEINS MARKET - GLOBAL MARKET ANALYSIS
6.1. RECOMBINANT PROTEINS - GLOBAL MARKET OVERVIEW
6.2. RECOMBINANT PROTEINS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. RECOMBINANT PROTEINS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. HORMONES
7.3.1. Overview
7.3.2. Hormones Market Forecast and Analysis
7.4. CYTOKINES
7.4.1. Overview
7.4.2. Cytokines Market Forecast and Analysis
7.5. PLASMA PROTEIN FACTOR
7.5.1. Overview
7.5.2. Plasma Protein Factor Market Forecast and Analysis
7.6. GROWTH FACTORS
7.6.1. Overview
7.6.2. Growth Factors Market Forecast and Analysis
7.7. RECOMBINANT METABOLIC ENZYMES
7.7.1. Overview
7.7.2. Recombinant Metabolic Enzymes Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. RECOMBINANT PROTEINS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DRUG DISCOVERY & DEVELOPMENT
8.3.1. Overview
8.3.2. Drug Discovery & Development Market Forecast and Analysis
8.4. BIOPHARMACEUTICAL PRODUCTION
8.4.1. Overview
8.4.2. Biopharmaceutical Production Market Forecast and Analysis
8.5. BASIC RESEARCH
8.5.1. Overview
8.5.2. Basic Research Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. RECOMBINANT PROTEINS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. BIOPHARMACEUTICAL COMPANIES
9.3.1. Overview
9.3.2. Biopharmaceutical Companies Market Forecast and Analysis
9.4. ACADEMIC & RESEARCH INSTITUTES
9.4.1. Overview
9.4.2. Academic & Research Institutes Market Forecast and Analysis
9.5. CONTRACT RESEARCH ORGANIZATIONS
9.5.1. Overview
9.5.2. Contract Research Organizations Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. RECOMBINANT PROTEINS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Recombinant Proteins Market Overview
10.1.2 North America Recombinant Proteins Market Forecasts and Analysis
10.1.3 North America Recombinant Proteins Market Forecasts and Analysis - By Product
10.1.4 North America Recombinant Proteins Market Forecasts and Analysis - By Application
10.1.5 North America Recombinant Proteins Market Forecasts and Analysis - By End User
10.1.6 North America Recombinant Proteins Market Forecasts and Analysis - By Countries
10.1.6.1 United States Recombinant Proteins Market
10.1.6.1.1 United States Recombinant Proteins Market by Product
10.1.6.1.2 United States Recombinant Proteins Market by Application
10.1.6.1.3 United States Recombinant Proteins Market by End User
10.1.6.2 Canada Recombinant Proteins Market
10.1.6.2.1 Canada Recombinant Proteins Market by Product
10.1.6.2.2 Canada Recombinant Proteins Market by Application
10.1.6.2.3 Canada Recombinant Proteins Market by End User
10.1.6.3 Mexico Recombinant Proteins Market
10.1.6.3.1 Mexico Recombinant Proteins Market by Product
10.1.6.3.2 Mexico Recombinant Proteins Market by Application
10.1.6.3.3 Mexico Recombinant Proteins Market by End User
10.2. EUROPE
10.2.1 Europe Recombinant Proteins Market Overview
10.2.2 Europe Recombinant Proteins Market Forecasts and Analysis
10.2.3 Europe Recombinant Proteins Market Forecasts and Analysis - By Product
10.2.4 Europe Recombinant Proteins Market Forecasts and Analysis - By Application
10.2.5 Europe Recombinant Proteins Market Forecasts and Analysis - By End User
10.2.6 Europe Recombinant Proteins Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Recombinant Proteins Market
10.2.6.1.1 Germany Recombinant Proteins Market by Product
10.2.6.1.2 Germany Recombinant Proteins Market by Application
10.2.6.1.3 Germany Recombinant Proteins Market by End User
10.2.6.2 France Recombinant Proteins Market
10.2.6.2.1 France Recombinant Proteins Market by Product
10.2.6.2.2 France Recombinant Proteins Market by Application
10.2.6.2.3 France Recombinant Proteins Market by End User
10.2.6.3 Italy Recombinant Proteins Market
10.2.6.3.1 Italy Recombinant Proteins Market by Product
10.2.6.3.2 Italy Recombinant Proteins Market by Application
10.2.6.3.3 Italy Recombinant Proteins Market by End User
10.2.6.4 Spain Recombinant Proteins Market
10.2.6.4.1 Spain Recombinant Proteins Market by Product
10.2.6.4.2 Spain Recombinant Proteins Market by Application
10.2.6.4.3 Spain Recombinant Proteins Market by End User
10.2.6.5 United Kingdom Recombinant Proteins Market
10.2.6.5.1 United Kingdom Recombinant Proteins Market by Product
10.2.6.5.2 United Kingdom Recombinant Proteins Market by Application
10.2.6.5.3 United Kingdom Recombinant Proteins Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Recombinant Proteins Market Overview
10.3.2 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis
10.3.3 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Recombinant Proteins Market
10.3.6.1.1 Australia Recombinant Proteins Market by Product
10.3.6.1.2 Australia Recombinant Proteins Market by Application
10.3.6.1.3 Australia Recombinant Proteins Market by End User
10.3.6.2 China Recombinant Proteins Market
10.3.6.2.1 China Recombinant Proteins Market by Product
10.3.6.2.2 China Recombinant Proteins Market by Application
10.3.6.2.3 China Recombinant Proteins Market by End User
10.3.6.3 India Recombinant Proteins Market
10.3.6.3.1 India Recombinant Proteins Market by Product
10.3.6.3.2 India Recombinant Proteins Market by Application
10.3.6.3.3 India Recombinant Proteins Market by End User
10.3.6.4 Japan Recombinant Proteins Market
10.3.6.4.1 Japan Recombinant Proteins Market by Product
10.3.6.4.2 Japan Recombinant Proteins Market by Application
10.3.6.4.3 Japan Recombinant Proteins Market by End User
10.3.6.5 South Korea Recombinant Proteins Market
10.3.6.5.1 South Korea Recombinant Proteins Market by Product
10.3.6.5.2 South Korea Recombinant Proteins Market by Application
10.3.6.5.3 South Korea Recombinant Proteins Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Recombinant Proteins Market Overview
10.4.2 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis
10.4.3 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Recombinant Proteins Market
10.4.6.1.1 South Africa Recombinant Proteins Market by Product
10.4.6.1.2 South Africa Recombinant Proteins Market by Application
10.4.6.1.3 South Africa Recombinant Proteins Market by End User
10.4.6.2 Saudi Arabia Recombinant Proteins Market
10.4.6.2.1 Saudi Arabia Recombinant Proteins Market by Product
10.4.6.2.2 Saudi Arabia Recombinant Proteins Market by Application
10.4.6.2.3 Saudi Arabia Recombinant Proteins Market by End User
10.4.6.3 U.A.E Recombinant Proteins Market
10.4.6.3.1 U.A.E Recombinant Proteins Market by Product
10.4.6.3.2 U.A.E Recombinant Proteins Market by Application
10.4.6.3.3 U.A.E Recombinant Proteins Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Recombinant Proteins Market Overview
10.5.2 South and Central America Recombinant Proteins Market Forecasts and Analysis
10.5.3 South and Central America Recombinant Proteins Market Forecasts and Analysis - By Product
10.5.4 South and Central America Recombinant Proteins Market Forecasts and Analysis - By Application
10.5.5 South and Central America Recombinant Proteins Market Forecasts and Analysis - By End User
10.5.6 South and Central America Recombinant Proteins Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Recombinant Proteins Market
10.5.6.1.1 Brazil Recombinant Proteins Market by Product
10.5.6.1.2 Brazil Recombinant Proteins Market by Application
10.5.6.1.3 Brazil Recombinant Proteins Market by End User
10.5.6.2 Argentina Recombinant Proteins Market
10.5.6.2.1 Argentina Recombinant Proteins Market by Product
10.5.6.2.2 Argentina Recombinant Proteins Market by Application
10.5.6.2.3 Argentina Recombinant Proteins Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. RECOMBINANT PROTEINS MARKET, KEY COMPANY PROFILES
12.1. CROWN BIOSCIENCE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PROSPEC-TANY TECHNOGENE LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BPS BIOSCIENCE, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVOPROTEIN
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PEPROTECH, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ELI LILLY AND COMPANY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MERCK & CO., INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PROTEINTECH GROUP
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GENSCRIPT
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. GLAXOSMITHKLINE PLC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Recombinant Proteins Market - By Product
1.3.2 Recombinant Proteins Market - By Application
1.3.3 Recombinant Proteins Market - By End User
1.3.4 Recombinant Proteins Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. RECOMBINANT PROTEINS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RECOMBINANT PROTEINS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. RECOMBINANT PROTEINS MARKET - GLOBAL MARKET ANALYSIS
6.1. RECOMBINANT PROTEINS - GLOBAL MARKET OVERVIEW
6.2. RECOMBINANT PROTEINS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. RECOMBINANT PROTEINS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. HORMONES
7.3.1. Overview
7.3.2. Hormones Market Forecast and Analysis
7.4. CYTOKINES
7.4.1. Overview
7.4.2. Cytokines Market Forecast and Analysis
7.5. PLASMA PROTEIN FACTOR
7.5.1. Overview
7.5.2. Plasma Protein Factor Market Forecast and Analysis
7.6. GROWTH FACTORS
7.6.1. Overview
7.6.2. Growth Factors Market Forecast and Analysis
7.7. RECOMBINANT METABOLIC ENZYMES
7.7.1. Overview
7.7.2. Recombinant Metabolic Enzymes Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. RECOMBINANT PROTEINS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DRUG DISCOVERY & DEVELOPMENT
8.3.1. Overview
8.3.2. Drug Discovery & Development Market Forecast and Analysis
8.4. BIOPHARMACEUTICAL PRODUCTION
8.4.1. Overview
8.4.2. Biopharmaceutical Production Market Forecast and Analysis
8.5. BASIC RESEARCH
8.5.1. Overview
8.5.2. Basic Research Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. RECOMBINANT PROTEINS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. BIOPHARMACEUTICAL COMPANIES
9.3.1. Overview
9.3.2. Biopharmaceutical Companies Market Forecast and Analysis
9.4. ACADEMIC & RESEARCH INSTITUTES
9.4.1. Overview
9.4.2. Academic & Research Institutes Market Forecast and Analysis
9.5. CONTRACT RESEARCH ORGANIZATIONS
9.5.1. Overview
9.5.2. Contract Research Organizations Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. RECOMBINANT PROTEINS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Recombinant Proteins Market Overview
10.1.2 North America Recombinant Proteins Market Forecasts and Analysis
10.1.3 North America Recombinant Proteins Market Forecasts and Analysis - By Product
10.1.4 North America Recombinant Proteins Market Forecasts and Analysis - By Application
10.1.5 North America Recombinant Proteins Market Forecasts and Analysis - By End User
10.1.6 North America Recombinant Proteins Market Forecasts and Analysis - By Countries
10.1.6.1 United States Recombinant Proteins Market
10.1.6.1.1 United States Recombinant Proteins Market by Product
10.1.6.1.2 United States Recombinant Proteins Market by Application
10.1.6.1.3 United States Recombinant Proteins Market by End User
10.1.6.2 Canada Recombinant Proteins Market
10.1.6.2.1 Canada Recombinant Proteins Market by Product
10.1.6.2.2 Canada Recombinant Proteins Market by Application
10.1.6.2.3 Canada Recombinant Proteins Market by End User
10.1.6.3 Mexico Recombinant Proteins Market
10.1.6.3.1 Mexico Recombinant Proteins Market by Product
10.1.6.3.2 Mexico Recombinant Proteins Market by Application
10.1.6.3.3 Mexico Recombinant Proteins Market by End User
10.2. EUROPE
10.2.1 Europe Recombinant Proteins Market Overview
10.2.2 Europe Recombinant Proteins Market Forecasts and Analysis
10.2.3 Europe Recombinant Proteins Market Forecasts and Analysis - By Product
10.2.4 Europe Recombinant Proteins Market Forecasts and Analysis - By Application
10.2.5 Europe Recombinant Proteins Market Forecasts and Analysis - By End User
10.2.6 Europe Recombinant Proteins Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Recombinant Proteins Market
10.2.6.1.1 Germany Recombinant Proteins Market by Product
10.2.6.1.2 Germany Recombinant Proteins Market by Application
10.2.6.1.3 Germany Recombinant Proteins Market by End User
10.2.6.2 France Recombinant Proteins Market
10.2.6.2.1 France Recombinant Proteins Market by Product
10.2.6.2.2 France Recombinant Proteins Market by Application
10.2.6.2.3 France Recombinant Proteins Market by End User
10.2.6.3 Italy Recombinant Proteins Market
10.2.6.3.1 Italy Recombinant Proteins Market by Product
10.2.6.3.2 Italy Recombinant Proteins Market by Application
10.2.6.3.3 Italy Recombinant Proteins Market by End User
10.2.6.4 Spain Recombinant Proteins Market
10.2.6.4.1 Spain Recombinant Proteins Market by Product
10.2.6.4.2 Spain Recombinant Proteins Market by Application
10.2.6.4.3 Spain Recombinant Proteins Market by End User
10.2.6.5 United Kingdom Recombinant Proteins Market
10.2.6.5.1 United Kingdom Recombinant Proteins Market by Product
10.2.6.5.2 United Kingdom Recombinant Proteins Market by Application
10.2.6.5.3 United Kingdom Recombinant Proteins Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Recombinant Proteins Market Overview
10.3.2 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis
10.3.3 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Recombinant Proteins Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Recombinant Proteins Market
10.3.6.1.1 Australia Recombinant Proteins Market by Product
10.3.6.1.2 Australia Recombinant Proteins Market by Application
10.3.6.1.3 Australia Recombinant Proteins Market by End User
10.3.6.2 China Recombinant Proteins Market
10.3.6.2.1 China Recombinant Proteins Market by Product
10.3.6.2.2 China Recombinant Proteins Market by Application
10.3.6.2.3 China Recombinant Proteins Market by End User
10.3.6.3 India Recombinant Proteins Market
10.3.6.3.1 India Recombinant Proteins Market by Product
10.3.6.3.2 India Recombinant Proteins Market by Application
10.3.6.3.3 India Recombinant Proteins Market by End User
10.3.6.4 Japan Recombinant Proteins Market
10.3.6.4.1 Japan Recombinant Proteins Market by Product
10.3.6.4.2 Japan Recombinant Proteins Market by Application
10.3.6.4.3 Japan Recombinant Proteins Market by End User
10.3.6.5 South Korea Recombinant Proteins Market
10.3.6.5.1 South Korea Recombinant Proteins Market by Product
10.3.6.5.2 South Korea Recombinant Proteins Market by Application
10.3.6.5.3 South Korea Recombinant Proteins Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Recombinant Proteins Market Overview
10.4.2 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis
10.4.3 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Recombinant Proteins Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Recombinant Proteins Market
10.4.6.1.1 South Africa Recombinant Proteins Market by Product
10.4.6.1.2 South Africa Recombinant Proteins Market by Application
10.4.6.1.3 South Africa Recombinant Proteins Market by End User
10.4.6.2 Saudi Arabia Recombinant Proteins Market
10.4.6.2.1 Saudi Arabia Recombinant Proteins Market by Product
10.4.6.2.2 Saudi Arabia Recombinant Proteins Market by Application
10.4.6.2.3 Saudi Arabia Recombinant Proteins Market by End User
10.4.6.3 U.A.E Recombinant Proteins Market
10.4.6.3.1 U.A.E Recombinant Proteins Market by Product
10.4.6.3.2 U.A.E Recombinant Proteins Market by Application
10.4.6.3.3 U.A.E Recombinant Proteins Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Recombinant Proteins Market Overview
10.5.2 South and Central America Recombinant Proteins Market Forecasts and Analysis
10.5.3 South and Central America Recombinant Proteins Market Forecasts and Analysis - By Product
10.5.4 South and Central America Recombinant Proteins Market Forecasts and Analysis - By Application
10.5.5 South and Central America Recombinant Proteins Market Forecasts and Analysis - By End User
10.5.6 South and Central America Recombinant Proteins Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Recombinant Proteins Market
10.5.6.1.1 Brazil Recombinant Proteins Market by Product
10.5.6.1.2 Brazil Recombinant Proteins Market by Application
10.5.6.1.3 Brazil Recombinant Proteins Market by End User
10.5.6.2 Argentina Recombinant Proteins Market
10.5.6.2.1 Argentina Recombinant Proteins Market by Product
10.5.6.2.2 Argentina Recombinant Proteins Market by Application
10.5.6.2.3 Argentina Recombinant Proteins Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. RECOMBINANT PROTEINS MARKET, KEY COMPANY PROFILES
12.1. CROWN BIOSCIENCE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PROSPEC-TANY TECHNOGENE LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BPS BIOSCIENCE, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVOPROTEIN
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PEPROTECH, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ELI LILLY AND COMPANY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MERCK & CO., INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PROTEINTECH GROUP
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GENSCRIPT
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. GLAXOSMITHKLINE PLC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Crown Bioscience Inc.
2. Prospec-Tany Technogene Ltd.
3. BPS Bioscience, Inc.
4. Novoprotein
5. PeproTech, Inc.
6. Eli Lilly and Company
7. Merck & Co., Inc.
8. Proteintech Group
9. GenScript
10. GlaxoSmithKline plc
1. Crown Bioscience Inc.
2. Prospec-Tany Technogene Ltd.
3. BPS Bioscience, Inc.
4. Novoprotein
5. PeproTech, Inc.
6. Eli Lilly and Company
7. Merck & Co., Inc.
8. Proteintech Group
9. GenScript
10. GlaxoSmithKline plc